GB-234

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGB-234
Drug Alias NameGB-234
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGenor Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenor Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A